Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Sell
413,425
-455
-0.1% -$3.01K 0.06% 293
2026
Q1
$2.56M Sell
413,880
-2,120
-0.5% -$13.1K 0.06% 296
2025
Q4
$2.8M Buy
416,000
+51,900
+14% +$389K 0.08% 248
2025
Q3
$2.97M Buy
+364,100
New +$2.72M 0.08% 265

Other funds holding INGN

CSM Advisors's INGN Position: Q2 2026 in Review

CSM Advisors reduced its Inogen (INGN) stake by 0.11% in Q2 2026, selling an estimated $3.01K and leaving 413,425 shares worth $2.67M. The position accounts for 0.06% of the portfolio, ranked #293.

CSM Advisors first reported a position in INGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.97M in Q3 2025. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • CSM Advisors held 413,425 shares of Inogen worth $2.67M as of Q2 2026.
  • CSM Advisors sold 455 Inogen shares in Q2 2026, an estimated $3.01K.
  • Inogen made up 0.06% of CSM Advisors's portfolio in Q2 2026, its #293 holding.
  • CSM Advisors first reported a position in Inogen in Q3 2025 and has held it in 4 quarters since.
  • CSM Advisors's Inogen position peaked at $2.97M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.